In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other most oversold healthcare stocks to buy now. Are Healthcare Costs Rising in the US?
The consensus price target for CRISPR Therapeutics AG (NASDAQ:CRSP) has been adjusted from $72.75 to $65, reflecting changes in financial performance and industry developments. Despite a quarterly ...
XCMG Construction Machinery Co. Ltd.-1.64% ¥99.14B Hitachi Construction Machinery Co. Ltd.-0.79% ¥828.7B Doosan Bobcat Inc. 2.65% ₩5.05T HD Hyundai Infracore Co. Ltd. 0.57% ₩1.69T HD Hyundai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback